170 related articles for article (PubMed ID: 34253743)
1. Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro.
Cagno V; Medaglia C; Cerny A; Cerny T; Zwygart AC; Cerny E; Tapparel C
Sci Rep; 2021 Jul; 11(1):14295. PubMed ID: 34253743
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue inhibits replication of SARS-CoV-2 in vitro.
Gendrot M; Andreani J; Duflot I; Boxberger M; Le Bideau M; Mosnier J; Jardot P; Fonta I; Rolland C; Bogreau H; Hutter S; La Scola B; Pradines B
Int J Antimicrob Agents; 2020 Dec; 56(6):106202. PubMed ID: 33075512
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19.
Jin C; Yu B; Zhang J; Wu H; Zhou X; Yao H; Liu F; Lu X; Cheng L; Jiang M; Wu N
BMC Infect Dis; 2021 Apr; 21(1):357. PubMed ID: 33863281
[TBL] [Abstract][Full Text] [Related]
4. Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin.
Svyatchenko VA; Nikonov SD; Mayorov AP; Gelfond ML; Loktev VB
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102112. PubMed ID: 33249118
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
[TBL] [Abstract][Full Text] [Related]
6. Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus.
Vitner EB; Achdout H; Avraham R; Politi B; Cherry L; Tamir H; Yahalom-Ronen Y; Paran N; Melamed S; Erez N; Israely T
J Biol Chem; 2021; 296():100470. PubMed ID: 33639165
[TBL] [Abstract][Full Text] [Related]
7. Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers.
Monge FA; Jagadesan P; Bondu V; Donabedian PL; Ista L; Chi EY; Schanze KS; Whitten DG; Kell AM
ACS Appl Mater Interfaces; 2020 Dec; 12(50):55688-55695. PubMed ID: 33267577
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2.
Khaiboullina S; Uppal T; Dhabarde N; Subramanian VR; Verma SC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33374195
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
[TBL] [Abstract][Full Text] [Related]
10. p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein.
Panagiotopoulos A; Tseliou M; Karakasiliotis I; Kotzampasi DM; Daskalakis V; Kesesidis N; Notas G; Lionis C; Kampa M; Pirintsos S; Sourvinos G; Castanas E
Pharmacol Res Perspect; 2021 Aug; 9(4):e00798. PubMed ID: 34128351
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
[TBL] [Abstract][Full Text] [Related]
12. Amantadine Inhibits SARS-CoV-2 In Vitro.
Fink K; Nitsche A; Neumann M; Grossegesse M; Eisele KH; Danysz W
Viruses; 2021 Mar; 13(4):. PubMed ID: 33804989
[TBL] [Abstract][Full Text] [Related]
13. Virucidal Efficacy of Blue LED and Far-UVC Light Disinfection against Feline Infectious Peritonitis Virus as a Model for SARS-CoV-2.
Gardner A; Ghosh S; Dunowska M; Brightwell G
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452302
[TBL] [Abstract][Full Text] [Related]
14. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
16. Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection.
Melano I; Kuo LL; Lo YC; Sung PW; Tien N; Su WC
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372507
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses.
Fomenko VV; Rudometova NB; Yarovaya OI; Rogachev AD; Fando AA; Zaykovskaya AV; Komarova NI; Shcherbakov DN; Pyankov OV; Pokrovsky AG; Karpenko LI; Maksyutov RA; Salakhutdinov NF
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011529
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of methylene blue based photodynamic inactivation (PDI) against intracellular B-CoV and SARS-CoV2 viruses under different light sources in vitro as a basis for new local treatment strategies in the early phase of a Covid19 infection.
Arentz J; von der Heide HJ
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102642. PubMed ID: 34863949
[TBL] [Abstract][Full Text] [Related]
19. Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations.
Dabholkar N; Gorantla S; Dubey SK; Alexander A; Taliyan R; Singhvi G
Biomed Pharmacother; 2021 Oct; 142():112023. PubMed ID: 34399199
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
